New techniques in biology and molecular genetics have advanced diagnosis because we can determine the genes that a tumour has through its DNA content, as well as other through other data that are directly related to their behaviour and their response to various treatments.
Our collaboration with the Molecular Biology Laboratory at the 12 de Octubre Hospital in Madrid and the services of other specialised research centres in the USA and Europe, such as Target-Now from Caris Life Sciences, CancerType from Genomic Health, PAM50 from NanoString, and many others, enables the study of new agents that are encountered at HC Marbella.
HC Marbella has a unit specifically for the study of the use of drugs in early stages, and it has conducted about 200 studies of more than 1,000 patients treated with new therapeutic strategies. Our team is accredited by the European Commission.
HOSPITALES, S.L.U. ensures that all data collected through the online form will be used in the manner and with the limitations and rights provided for in Organic Law 15/1999 of December 13 on the Protection of Personal Data (LOPD). The processing and management of this data meet the provisions of Royal Decree 994/1999, of 11 June, which approves the Regulation on security measures for automated files containing personal data.
C/ Ventura del Mar n┬║ 11,
29660 Marbella (M├ílaga) Espa├▒a
Coordinates: Latitude 36.485664 ┬Ě Longitude -4.970016
See on Google maps